Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk.

Van Besien K, Bachier-Rodriguez L, Satlin M, Brown MA, Gergis U, Guarneri D, Hsu J, Phillips AA, Mayer SA, Singh AD, Soave R, Rossi A, Small CB, Walsh TJ, Rennert H, Shore TB. Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.

View in: PubMed

collapse authors with profiles